| abstract |
A method of treating type 2 diabetes mellitus and disorders associated with diabetes mellitus, which method comprises administering to a human or non-human mammal in need thereof an effective, non-toxic amount of an insulin sensitizer to provide a plasma. concentration of the insulin sensitizer at at least one threshold level (the "threshold plasma concentration") within the range of effective plasma levels of the insulin sensitizer, preparations for use in such a method and methods for determining active ingredient plasma concentrations by such methods. |